Advertisement
Organisation › Details
Mattern Pharmaceuticals AG
M et P owns a proprietary nasal drug delivery technology. Apart from the product Nasobol(r) and based on that technology, the Company develops drugs especially to improve Central Nervous System disorders. *
Start | 1997-01-01 established | |
Group | Mattern Pharmaceuticals (M et P / M & P) (Group) | |
Industry | respiratory drug delivery technology | |
Industry 2 | CNS drug (neurological drug) | |
Region | Stans NW | |
Country | Switzerland | |
Street | 3 Mühlebachstr. | |
City | 6370 Stans NW | |
Tel | +41-41-618-3030 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top